Retinol-binding protein 4 & atherosclerosis: Risk factor or innocent bystander?

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 38-39

  von Eynatten, Maximilian ^a   Humpert, Per M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADIPOCYTE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; GENE DELETION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; FEMALE; HUMANS; MALE; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS;

EID: 68949218847     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.038     Document Type: Note

References (18)

1. Halaas J.L., Gajiwala K., Maffei M., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
2. Rasouli N., and Kern P.A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93 (2008) S64-S73
3. Zanotti G., and Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 69 (2004) 271-295
4. Yang Q., Graham T.E., Mody N., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
5. von Eynatten M., Lepper P.M., Liu D., et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 50 (2007) 1930-1937
6. Broch M., Vendrell J., Ricart W., Richart C., and Fernández-Real J.M. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 30 (2007) 1802-1806
7. Janke J., Engeli S., Boschmann M., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810
8. von Eynatten M., and Humpert P.M. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn 8 (2008) 289-299
9. Graham T.E., Yang Q., Blüher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
10. Klöting N., Graham T.E., Berndt J., et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6 (2007) 79-87
11. Ingelsson E., Sundström J., Melhus H., et al. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206 (2009) 239-244
12. Ingelsson E., and Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 32 (2009) 733-735
13. Mallat Z., Simon T., Benessiano J., et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 94 (2009) 255-260
14. Cabré A., Lázaro I., Girona J., et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 262 (2007) 496-503
15. Park S.E., Kim D.H., Lee J.H., et al. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis. 204 (2009) 23-25
16. Gerber L.E., and Erdman Jr. J.W. Retinoic acid and hypertriglyceridemia. Ann N Y Acad Sci 359 (1981) 391-392
17. Vu-Dac N., Gervois P., Torra I.P., et al. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J Clin Invest 102 (1998) 625-632
18. Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia 48 (2005) 2203-2205